Compare Ross Stores, Inc. (ROST) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ross Stores, Inc. vs Twist Bioscience Corp — how do they compare? Ross Stores, Inc. trades at $225.21 (market cap $71.96B), while Twist Bioscience Corp trades at $125.52 (market cap $8.26B). The key difference: Ross Stores, Inc. is far larger — about 8.7× Twist Bioscience Corp's market cap, and Ross Stores, Inc. pays a 0.79% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| ROST | TWST | |
|---|---|---|
Market Cap | $71.96B | $8.26B |
Sector | Consumer Cyclical | Health |
52-Week High | $255.23 | $153.10 |
52-Week Low | $144.67 | $24.16 |
Enterprise Value | $72.41B | $8.18B |
Dividend Yield | 0.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ross Stores (ROST) trades at $229.31, down 0.6% on the day, amid a bearish technical signal but strong fundamental performance. The company has consistently beaten earnings estimates, with Q2 2026 EPS of $2.66 surpassing the $1.95 forecast, and raised its full-year outlook. Revenue reached $21.13B in 2025, with net income of $2.09B and robust profitability metrics, including a 42.63% ROE. Analysts maintain a bullish consensus with a $271.33 price target, though technical indicators show near-term resistance.
The outlook for ROST is positive, driven by strong execution, expanding margins, and resilient consumer demand for value retail. Investment opportunities include continued earnings growth and potential upside to analyst targets. Key risks involve macroeconomic sensitivity, competitive pressures, and any deviation from its traffic growth trajectory. The stock's valuation at a P/E of 27.73 requires sustained performance to justify further gains.
Twist Bioscience (TWST) trades at $128.06, up 2.68% with a bearish technical signal despite recent AI-driven momentum. The company shows strong revenue growth (2025: $377M, 2026: $432M projected) but continues to report significant losses with negative net margins. Recent news highlights AI partnerships and a $300M stock offering, while analyst consensus remains predominantly bullish with 78.6% buy ratings.
TWST presents a high-risk growth opportunity with accelerating revenue but persistent profitability challenges. The stock's valuation appears stretched at P/S of 18.09, requiring successful execution on AI initiatives and path to EBITDA breakeven. Key risks include cash burn, competitive pressures, and dependence on emerging AI-driven drug discovery markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
